Virologie et Pathologie Humaine-VirPath team, Centre International de Recherche en Infectiologie (CIRI), INSERM U1111, ENS Lyon, Université Claude Bernard Lyon 1, Université de Lyon, Lyon, CNRS UMR5308, France.
Laboratoire des Pathogènes Emergents, Fondation Mérieux. CIRI, UCBL1- INSERM U1111, ENS Lyon, CNRS UMR5308, Lyon, France.
Sci Rep. 2018 Feb 27;8(1):3746. doi: 10.1038/s41598-018-22139-6.
The interplay between influenza A viruses (IAV) and the p53 pathway has been reported in several studies, highlighting the antiviral contribution of p53. Here, we investigated the impact of IAV on the E3-ubiquitin ligase Mdm2, a major regulator of p53, and observed that IAV targets Mdm2, notably via its non-structural protein (NS1), therefore altering Mdm2 stability, p53/Mdm2 interaction and regulatory loop during the time-course of infection. This study also highlights a new antiviral facet of Mdm2 possibly increasing the list of its many p53-independent functions. Altogether, our work contributes to better understand the mechanisms underlining the complex interactions between IAV and the p53 pathway, for which both NS1 and Mdm2 arise as key players.
已有多项研究报道甲型流感病毒(IAV)与 p53 通路之间的相互作用,突出了 p53 的抗病毒贡献。在这里,我们研究了 IAV 对 E3-泛素连接酶 Mdm2 的影响,Mdm2 是 p53 的主要调节因子,我们观察到 IAV 靶向 Mdm2,特别是通过其非结构蛋白(NS1),从而改变 Mdm2 的稳定性、p53/Mdm2 相互作用和感染过程中的调节环。这项研究还强调了 Mdm2 的一个新的抗病毒方面,可能增加了其许多非依赖 p53 的功能列表。总的来说,我们的工作有助于更好地理解 IAV 与 p53 通路之间复杂相互作用的机制,其中 NS1 和 Mdm2 都是关键参与者。